Latest Conference Articles

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community.

Study evaluates OC-01 (varenicline solution) as a treatment for symptoms and signs of dry eye

Study evaluates OC-01 (varenicline solution) as a treatment for symptoms and signs of dry eye

May 11th 2022

ARVO

Takeaway: there doesn't seem to be a specific dry eye phenotype that does better or worse.

Cell therapy trial shows promising results for patients with advanced dry AMD

Cell therapy trial shows promising results for patients with advanced dry AMD

May 10th 2022

ARVO

The OpRegen trial is a cell therapy trial, looking to explore potential safety and efficacy for patients with advanced dry age-related macular degeneration (AMD).

New PRO instrument helps measure patient experience with therapies such as anti-VEGF agents, lasers to treat their eye disease

New PRO instrument helps measure patient experience with therapies such as anti-VEGF agents, lasers to treat their eye disease

May 9th 2022

ARVO

Diana Do, MD, professor of ophthalmology at Stanford's Byers Eye Institute, presents research on a newly developed, novel patient-reported outcome instrument (PRO) for patients who have proliferative diabetic retinopathy and who are undergoing treatment with either intravitreal anti-VEGF therapy, or panretinal photocoagulation.

New noninvasive technology shows positive safety and efficacy for the treatment of open angle glaucoma

New noninvasive technology shows positive safety and efficacy for the treatment of open angle glaucoma

May 5th 2022

ASCRS

Two year data shows a promising future for the OCD guided, noninvasive technology for glaucoma treatment.

Cataract classification method allows for higher success rates of cataract surgery

Cataract classification method allows for higher success rates of cataract surgery

May 5th 2022

ASCRS

Alex Dastgheib, MD, ABO, discusses the findings of the paper, "325 Cases of Phacoemulsification in Blind Cataracts," presented at the 2022 ASCRS conference in Washington, DC. The paper won the Challenging Cases session during the meeting.

YOSEMITE and RHINE: 2-year results of faricimab in diabetic macular edema indicate reduced treatment burden

YOSEMITE and RHINE: 2-year results of faricimab in diabetic macular edema indicate reduced treatment burden

May 4th 2022

ARVO

Jennifer I. Lim, MD, FARVO, FASRS, reviews the 2-year results of the YOSEMITE and RHINE trials, outlining the efficacy, durability, and safety of faricimab in diabetic macular edema.

Beyeonics One exoscope offers an immersive experience that allows for better patient and surgeon outcomes

Beyeonics One exoscope offers an immersive experience that allows for better patient and surgeon outcomes

May 4th 2022

ASCRS

Jonathan Solomon, MD, shares his personal experience using the Beyeonics One exoscope, highlighting what makes this tool stand out.

Retrospective study shows toric IOL rotation rate to be low at 2.1%

Retrospective study shows toric IOL rotation rate to be low at 2.1%

May 4th 2022

ASCRS

Edward Hu, MD, PhD, looked at 812 toric IOLs utilized of various platforms, concluding a low total toric rotation rate at 2.1%.

Pilot study examines spectacle lenses to control myopia

Pilot study examines spectacle lenses to control myopia

May 3rd 2022

ARVO

In a poster presented at the Association for Research in Vision and Ophthalmology’s 2022 annual meeting in Denver, Eva Chamorro, PhD, MSc, points out that myopia control spectacle lenses affect the diurnal rhythms in the AL in young adult human and produced a small short-term increase in the AL that varies in intensity and time interval for each of the 3 studied lenses.